VEGFA and hepatocellular carcinoma: Fortunately, there is a growing array of effective systemic therapies, encompassing immune checkpoint inhibitors (ICIs), vascular endothelial growth factor (VEGF) inhibitors, and tyrosine kinase inhibitors (TKIs), for the treatment of advanced HCC [3, 4, 5].